0001124198 false 12-31 2023 Q1 9 1 0001124198 2023-01-01 2023-03-31 0001124198 2023-04-28 xbrli:shares iso4217:USD 0001124198 2022-01-01 2022-03-31 iso4217:USD xbrli:shares 0001124198 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2023-03-31 0001124198 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2022-12-31 0001124198 2023-03-31 0001124198 2022-12-31 0001124198 2021-12-31 0001124198 2022-03-31 0001124198 us-gaap:PreferredStockMember 2022-12-31 0001124198 us-gaap:CommonStockMember 2022-12-31 0001124198 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001124198 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001124198 us-gaap:RetainedEarningsMember 2022-12-31 0001124198 us-gaap:ParentMember 2022-12-31 0001124198 us-gaap:NoncontrollingInterestMember 2022-12-31 0001124198 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001124198 us-gaap:ParentMember 2023-01-01 2023-03-31 0001124198 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-03-31 0001124198 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001124198 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001124198 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001124198 us-gaap:PreferredStockMember 2023-03-31 0001124198 us-gaap:CommonStockMember 2023-03-31 0001124198 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001124198 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001124198 us-gaap:RetainedEarningsMember 2023-03-31 0001124198 us-gaap:ParentMember 2023-03-31 0001124198 us-gaap:NoncontrollingInterestMember 2023-03-31 0001124198 us-gaap:PreferredStockMember 2021-12-31 0001124198 us-gaap:CommonStockMember 2021-12-31 0001124198 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001124198 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001124198 us-gaap:RetainedEarningsMember 2021-12-31 0001124198 us-gaap:ParentMember 2021-12-31 0001124198 us-gaap:NoncontrollingInterestMember 2021-12-31 0001124198 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001124198 us-gaap:ParentMember 2022-01-01 2022-03-31 0001124198 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-03-31 0001124198 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0001124198 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001124198 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001124198 us-gaap:PreferredStockMember 2022-03-31 0001124198 us-gaap:CommonStockMember 2022-03-31 0001124198 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001124198 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001124198 us-gaap:RetainedEarningsMember 2022-03-31 0001124198 us-gaap:ParentMember 2022-03-31 0001124198 us-gaap:NoncontrollingInterestMember 2022-03-31 0001124198 us-gaap:ConvertiblePreferredStockMember 2023-01-01 2023-03-31 0001124198 us-gaap:ConvertiblePreferredStockMember 2022-01-01 2022-03-31 0001124198 flr:AllOtherClassesOfStockMember 2023-01-01 2023-03-31 0001124198 flr:AllOtherClassesOfStockMember 2022-01-01 2022-03-31 0001124198 us-gaap:SegmentContinuingOperationsMember us-gaap:OperatingSegmentsMember flr:EnergySolutionsSegmentMember 2023-01-01 2023-03-31 0001124198 us-gaap:SegmentContinuingOperationsMember us-gaap:OperatingSegmentsMember flr:EnergySolutionsSegmentMember 2022-01-01 2022-03-31 0001124198 us-gaap:SegmentContinuingOperationsMember us-gaap:OperatingSegmentsMember flr:UrbanSolutionsSegmentMember 2023-01-01 2023-03-31 0001124198 us-gaap:SegmentContinuingOperationsMember us-gaap:OperatingSegmentsMember flr:UrbanSolutionsSegmentMember 2022-01-01 2022-03-31 0001124198 us-gaap:SegmentContinuingOperationsMember us-gaap:OperatingSegmentsMember flr:MissionSolutionsSegmentMember 2023-01-01 2023-03-31 0001124198 us-gaap:SegmentContinuingOperationsMember us-gaap:OperatingSegmentsMember flr:MissionSolutionsSegmentMember 2022-01-01 2022-03-31 0001124198 us-gaap:SegmentContinuingOperationsMember us-gaap:AllOtherSegmentsMember us-gaap:OperatingSegmentsMember 2023-01-01 2023-03-31 0001124198 us-gaap:SegmentContinuingOperationsMember us-gaap:AllOtherSegmentsMember us-gaap:OperatingSegmentsMember 2022-01-01 2022-03-31 0001124198 us-gaap:SegmentContinuingOperationsMember us-gaap:OperatingSegmentsMember 2023-01-01 2023-03-31 0001124198 us-gaap:SegmentContinuingOperationsMember us-gaap:OperatingSegmentsMember 2022-01-01 2022-03-31 0001124198 us-gaap:SegmentContinuingOperationsMember 2023-01-01 2023-03-31 0001124198 us-gaap:SegmentContinuingOperationsMember 2022-01-01 2022-03-31 0001124198 flr:LargeLNGProjectMember flr:EnergySolutionsSegmentMember 2023-01-01 2023-03-31 0001124198 flr:EnergySolutionsSegmentMember 2023-01-01 2023-03-31 0001124198 flr:EnergySolutionsSegmentMember 2022-01-01 2022-03-31 0001124198 flr:LAXAutomatedPeopleMoverProjectMember flr:UrbanSolutionsSegmentMember 2023-01-01 2023-03-31 0001124198 srt:ConsolidationEliminationsMember flr:ProfessionalStaffingBusinessMember flr:UrbanSolutionsSegmentMember 2023-01-01 2023-03-31 0001124198 srt:ConsolidationEliminationsMember flr:ProfessionalStaffingBusinessMember flr:UrbanSolutionsSegmentMember 2022-01-01 2022-03-31 0001124198 flr:WeaponsFacilityProjectMember flr:MissionSolutionsSegmentMember 2023-01-01 2023-03-31 0001124198 us-gaap:SegmentContinuingOperationsMember us-gaap:AllOtherSegmentsMember us-gaap:OperatingSegmentsMember flr:NuScalePowerLlcMember 2023-01-01 2023-03-31 0001124198 us-gaap:SegmentContinuingOperationsMember us-gaap:AllOtherSegmentsMember us-gaap:OperatingSegmentsMember flr:NuScalePowerLlcMember 2022-01-01 2022-03-31 0001124198 us-gaap:SegmentContinuingOperationsMember us-gaap:AllOtherSegmentsMember us-gaap:OperatingSegmentsMember flr:StorkHoldingBVMember 2023-01-01 2023-03-31 0001124198 us-gaap:SegmentContinuingOperationsMember us-gaap:AllOtherSegmentsMember us-gaap:OperatingSegmentsMember flr:StorkHoldingBVMember 2022-01-01 2022-03-31 0001124198 us-gaap:SegmentContinuingOperationsMember us-gaap:AllOtherSegmentsMember us-gaap:OperatingSegmentsMember flr:AMECOMember 2023-01-01 2023-03-31 0001124198 us-gaap:SegmentContinuingOperationsMember us-gaap:AllOtherSegmentsMember us-gaap:OperatingSegmentsMember flr:AMECOMember 2022-01-01 2022-03-31 0001124198 flr:FluorCorporationMember flr:NuScalePowerLlcMember us-gaap:DisposalGroupNotDiscontinuedOperationsMember 2023-03-31 xbrli:pure 0001124198 flr:AMECOMember us-gaap:DisposalGroupNotDiscontinuedOperationsMember 2023-01-01 2023-03-31 0001124198 us-gaap:OperatingSegmentsMember flr:EnergySolutionsSegmentMember 2023-03-31 0001124198 us-gaap:OperatingSegmentsMember flr:EnergySolutionsSegmentMember 2022-12-31 0001124198 us-gaap:OperatingSegmentsMember flr:UrbanSolutionsSegmentMember 2023-03-31 0001124198 us-gaap:OperatingSegmentsMember flr:UrbanSolutionsSegmentMember 2022-12-31 0001124198 us-gaap:OperatingSegmentsMember flr:MissionSolutionsSegmentMember 2023-03-31 0001124198 us-gaap:OperatingSegmentsMember flr:MissionSolutionsSegmentMember 2022-12-31 0001124198 us-gaap:OperatingSegmentsMember flr:OtherMember 2023-03-31 0001124198 us-gaap:OperatingSegmentsMember flr:OtherMember 2022-12-31 0001124198 us-gaap:CorporateNonSegmentMember 2023-03-31 0001124198 us-gaap:CorporateNonSegmentMember 2022-12-31 0001124198 srt:NorthAmericaMember 2023-01-01 2023-03-31 0001124198 srt:NorthAmericaMember 2022-01-01 2022-03-31 0001124198 srt:AsiaPacificMember 2023-01-01 2023-03-31 0001124198 srt:AsiaPacificMember 2022-01-01 2022-03-31 0001124198 srt:EuropeMember 2023-01-01 2023-03-31 0001124198 srt:EuropeMember 2022-01-01 2022-03-31 0001124198 flr:CentralAndSouthAmericaMember 2023-01-01 2023-03-31 0001124198 flr:CentralAndSouthAmericaMember 2022-01-01 2022-03-31 0001124198 flr:MiddleEastAndAfricaMember 2023-01-01 2023-03-31 0001124198 flr:MiddleEastAndAfricaMember 2022-01-01 2022-03-31 0001124198 flr:StorkAndAMECOMember flr:EnergySolutionsSegmentMember 2023-01-01 2023-03-31 0001124198 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember us-gaap:AccruedLiabilitiesMember 2023-03-31 0001124198 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember us-gaap:AccruedLiabilitiesMember 2022-12-31 0001124198 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember flr:AccountsAndNotesReceivableNetCurrentMember 2023-03-31 0001124198 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember flr:AccountsAndNotesReceivableNetCurrentMember 2022-12-31 0001124198 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember 2023-03-31 0001124198 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember 2022-12-31 0001124198 flr:FundingCommitmentMember us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember 2023-03-31 0001124198 us-gaap:PerformanceGuaranteeMember 2023-03-31 0001124198 us-gaap:PendingLitigationMember flr:SantosLtdMember 2016-12-13 2016-12-13 iso4217:AUD flr:referee 0001124198 us-gaap:PendingLitigationMember flr:SantosLtdMember 2016-12-13 0001124198 2018-09-01 2018-09-30 flr:action 0001124198 flr:SadaraChemicalCompanyMember us-gaap:PendingLitigationMember 2019-08-23 2019-08-23 0001124198 flr:SadaraChemicalCompanyMember us-gaap:PendingLitigationMember 2019-08-23 0001124198 flr:FluorTECHINTMember us-gaap:PendingLitigationMember 2016-08-12 0001124198 flr:BarrickMember flr:FluorTECHINTMember 2019-08-31 0001124198 flr:BarrickMember flr:FluorTECHINTMember srt:ParentCompanyMember 2019-08-31 0001124198 flr:BarrickMember srt:PartnershipInterestMember flr:FluorTECHINTMember 2019-08-31 0001124198 flr:FluorTECHINTMember us-gaap:PendingLitigationMember 2023-03-31 0001124198 flr:NorthTexasTollwayAuthorityMember us-gaap:PendingLitigationMember 2022-10-01 2022-10-31 0001124198 2024-04-01 2023-03-31 0001124198 2025-01-01 2023-03-31 0001124198 2026-01-01 2023-03-31 0001124198 flr:SeniorNotes1.750PercentDue21March2023Member 2023-03-31 0001124198 flr:SeniorNotes1.750PercentDue21March2023Member 2022-12-31 0001124198 us-gaap:OtherDebtSecuritiesMember 2023-03-31 0001124198 us-gaap:OtherDebtSecuritiesMember 2022-12-31 0001124198 flr:SeniorNotes3.5PercentDue15December2024Member 2023-03-31 0001124198 flr:SeniorNotes3.5PercentDue15December2024Member 2022-12-31 0001124198 flr:SeniorNotes4.25PercentDue15September2028Member 2023-03-31 0001124198 flr:SeniorNotes4.25PercentDue15September2028Member 2022-12-31 0001124198 us-gaap:LineOfCreditMember 2023-03-31 0001124198 flr:RevolvingLoanAndLetterOfCreditFacilityAgreementMember us-gaap:LineOfCreditMember flr:CommittedCreditLineMember 2023-03-31 0001124198 flr:RevolvingLoanAndLetterOfCreditFacilityAgreementMember us-gaap:LineOfCreditMember srt:MinimumMember flr:CommittedCreditLineMember 2023-01-01 2023-03-31 0001124198 srt:MaximumMember flr:RevolvingLoanAndLetterOfCreditFacilityAgreementMember us-gaap:LineOfCreditMember flr:CommittedCreditLineMember srt:SubsidiariesMember 2023-03-31 iso4217:EUR 0001124198 flr:RevolvingLoanAndLetterOfCreditFacilityAgreementMember us-gaap:LineOfCreditMember flr:CommittedCreditLineMember srt:SubsidiariesMember 2023-01-01 2023-03-31 0001124198 us-gaap:LineOfCreditMember flr:CommittedCreditLineMember 2023-03-31 0001124198 flr:UncommittedCreditLineMember us-gaap:LineOfCreditMember 2023-03-31 0001124198 flr:SeniorNotes1.750PercentDue21March2023Member 2023-01-01 2023-01-31 0001124198 2023-02-01 2023-02-28 0001124198 us-gaap:SubsequentEventMember 2023-04-01 2023-04-30 0001124198 us-gaap:ConvertiblePreferredStockMember 2023-01-01 2023-03-31 flr:segment 0001124198 us-gaap:ConvertiblePreferredStockMember 2023-03-31 0001124198 us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001124198 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2023-03-31 0001124198 us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001124198 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0001124198 us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember 2023-03-31 0001124198 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember 2023-03-31 0001124198 us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember 2022-12-31 0001124198 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember 2022-12-31 0001124198 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommodityContractMember 2023-03-31 0001124198 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommodityContractMember 2023-03-31 0001124198 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommodityContractMember 2022-12-31 0001124198 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommodityContractMember 2022-12-31 0001124198 flr:SMRWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001124198 flr:SMRWarrantsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2023-03-31 0001124198 flr:SMRWarrantsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001124198 flr:SMRWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001124198 flr:SMRWarrantsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0001124198 flr:SMRWarrantsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001124198 us-gaap:CashMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueInputsLevel1Member 2023-03-31 0001124198 us-gaap:CashMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueInputsLevel1Member 2023-03-31 0001124198 us-gaap:CashMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0001124198 us-gaap:CashMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0001124198 us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:CashEquivalentsMember 2023-03-31 0001124198 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:CashEquivalentsMember 2023-03-31 0001124198 us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:CashEquivalentsMember 2022-12-31 0001124198 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:CashEquivalentsMember 2022-12-31 0001124198 us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2023-03-31 0001124198 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-03-31 0001124198 us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-12-31 0001124198 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-12-31 0001124198 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001124198 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001124198 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001124198 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001124198 us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember flr:SeniorNotes1.750PercentDue21March2023Member 2023-03-31 0001124198 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember flr:SeniorNotes1.750PercentDue21March2023Member 2023-03-31 0001124198 us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember flr:SeniorNotes1.750PercentDue21March2023Member 2022-12-31 0001124198 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember flr:SeniorNotes1.750PercentDue21March2023Member 2022-12-31 0001124198 us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember flr:SeniorNotes3.5PercentDue15December2024Member 2023-03-31 0001124198 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember flr:SeniorNotes3.5PercentDue15December2024Member 2023-03-31 0001124198 us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember flr:SeniorNotes3.5PercentDue15December2024Member 2022-12-31 0001124198 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember flr:SeniorNotes3.5PercentDue15December2024Member 2022-12-31 0001124198 us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember flr:SeniorNotes4.25PercentDue15September2028Member 2023-03-31 0001124198 us-gaap:FairValueInputsLevel2Member flr:SeniorNotes4.25PercentDue15September2028Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-03-31 0001124198 us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember flr:SeniorNotes4.25PercentDue15September2028Member 2022-12-31 0001124198 us-gaap:FairValueInputsLevel2Member flr:SeniorNotes4.25PercentDue15September2028Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-12-31 0001124198 us-gaap:FairValueInputsLevel2Member us-gaap:NotesPayableOtherPayablesMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2023-03-31 0001124198 us-gaap:FairValueInputsLevel2Member us-gaap:NotesPayableOtherPayablesMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-03-31 0001124198 us-gaap:FairValueInputsLevel2Member us-gaap:NotesPayableOtherPayablesMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-12-31 0001124198 us-gaap:FairValueInputsLevel2Member us-gaap:NotesPayableOtherPayablesMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-12-31 0001124198 srt:ExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-03-31 0001124198 srt:ExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-03-31 0001124198 us-gaap:EmployeeStockOptionMember srt:ExecutiveOfficerMember 2023-01-01 2023-03-31 0001124198 us-gaap:EmployeeStockOptionMember srt:ExecutiveOfficerMember 2022-01-01 2022-03-31 0001124198 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-03-31 0001124198 us-gaap:PerformanceSharesMember srt:ExecutiveOfficerMember 2023-01-01 2023-03-31 0001124198 us-gaap:PerformanceSharesMember srt:ExecutiveOfficerMember 2022-01-01 2022-03-31 0001124198 us-gaap:PerformanceSharesMember 2023-01-01 2023-03-31 flr:period 0001124198 flr:VDIPlan2023Member 2023-01-01 2023-03-31 0001124198 flr:VDIPlan2022Member 2023-01-01 2023-03-31 0001124198 flr:VDIPlan2021Member 2023-01-01 2023-03-31 0001124198 flr:SGIAwardsMember us-gaap:GeneralAndAdministrativeExpenseMember srt:ExecutiveOfficerMember 2023-01-01 2023-03-31 0001124198 flr:SGIAwardsMember us-gaap:GeneralAndAdministrativeExpenseMember srt:ExecutiveOfficerMember 2022-01-01 2022-03-31 0001124198 us-gaap:GeneralAndAdministrativeExpenseMember us-gaap:PerformanceSharesMember srt:ExecutiveOfficerMember 2023-01-01 2023-03-31 0001124198 us-gaap:GeneralAndAdministrativeExpenseMember us-gaap:PerformanceSharesMember srt:ExecutiveOfficerMember 2022-01-01 2022-03-31 0001124198 flr:SGIAwardsMember srt:ExecutiveOfficerMember 2023-03-31 0001124198 flr:SGIAwardsMember srt:ExecutiveOfficerMember 2022-12-31 0001124198 us-gaap:PerformanceSharesMember srt:ExecutiveOfficerMember 2023-03-31 0001124198 us-gaap:PerformanceSharesMember srt:ExecutiveOfficerMember 2022-12-31 0001124198 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2023-01-01 2023-03-31 0001124198 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2022-01-01 2022-03-31 0001124198 flr:AccumulatedOtherComprehensiveIncomeLossEquityMethodInvestmentsIncludingPortionAttributableToNoncontrollingInterestMember 2023-01-01 2023-03-31 0001124198 flr:AccumulatedOtherComprehensiveIncomeLossEquityMethodInvestmentsIncludingPortionAttributableToNoncontrollingInterestMember 2022-01-01 2022-03-31 0001124198 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2023-01-01 2023-03-31 0001124198 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2022-01-01 2022-03-31 0001124198 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2023-01-01 2023-03-31 0001124198 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2022-01-01 2022-03-31 0001124198 us-gaap:AociAttributableToNoncontrollingInterestMember 2023-01-01 2023-03-31 0001124198 us-gaap:AociAttributableToNoncontrollingInterestMember 2022-01-01 2022-03-31 0001124198 us-gaap:AccumulatedTranslationAdjustmentMember 2022-12-31 0001124198 flr:AccumulatedOtherComprehensiveIncomeLossEquityMethodInvestmentsMember 2022-12-31 0001124198 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-12-31 0001124198 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-12-31 0001124198 us-gaap:AccumulatedTranslationAdjustmentMember 2023-01-01 2023-03-31 0001124198 flr:AccumulatedOtherComprehensiveIncomeLossEquityMethodInvestmentsMember 2023-01-01 2023-03-31 0001124198 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-01-01 2023-03-31 0001124198 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-01-01 2023-03-31 0001124198 us-gaap:AccumulatedTranslationAdjustmentMember 2023-03-31 0001124198 flr:AccumulatedOtherComprehensiveIncomeLossEquityMethodInvestmentsMember 2023-03-31 0001124198 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-03-31 0001124198 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-03-31 0001124198 us-gaap:AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember 2022-12-31 0001124198 flr:AccumulatedOtherComprehensiveIncomeLossEquityMethodInvestmentsAttributableToNoncontrollingInterestMember 2022-12-31 0001124198 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentAttributableToNoncontrollingInterestMember 2022-12-31 0001124198 us-gaap:AccumulatedGainLossNetCashFlowHedgeNoncontrollingInterestMember 2022-12-31 0001124198 us-gaap:AociAttributableToNoncontrollingInterestMember 2022-12-31 0001124198 us-gaap:AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember 2023-01-01 2023-03-31 0001124198 flr:AccumulatedOtherComprehensiveIncomeLossEquityMethodInvestmentsAttributableToNoncontrollingInterestMember 2023-01-01 2023-03-31 0001124198 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentAttributableToNoncontrollingInterestMember 2023-01-01 2023-03-31 0001124198 us-gaap:AccumulatedGainLossNetCashFlowHedgeNoncontrollingInterestMember 2023-01-01 2023-03-31 0001124198 us-gaap:AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember 2023-03-31 0001124198 flr:AccumulatedOtherComprehensiveIncomeLossEquityMethodInvestmentsAttributableToNoncontrollingInterestMember 2023-03-31 0001124198 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentAttributableToNoncontrollingInterestMember 2023-03-31 0001124198 us-gaap:AccumulatedGainLossNetCashFlowHedgeNoncontrollingInterestMember 2023-03-31 0001124198 us-gaap:AociAttributableToNoncontrollingInterestMember 2023-03-31 0001124198 us-gaap:AccumulatedTranslationAdjustmentMember 2021-12-31 0001124198 flr:AccumulatedOtherComprehensiveIncomeLossEquityMethodInvestmentsMember 2021-12-31 0001124198 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-12-31 0001124198 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-12-31 0001124198 us-gaap:AccumulatedTranslationAdjustmentMember 2022-01-01 2022-03-31 0001124198 flr:AccumulatedOtherComprehensiveIncomeLossEquityMethodInvestmentsMember 2022-01-01 2022-03-31 0001124198 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-01-01 2022-03-31 0001124198 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-01-01 2022-03-31 0001124198 us-gaap:AccumulatedTranslationAdjustmentMember 2022-03-31 0001124198 flr:AccumulatedOtherComprehensiveIncomeLossEquityMethodInvestmentsMember 2022-03-31 0001124198 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-03-31 0001124198 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-03-31 0001124198 us-gaap:AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember 2021-12-31 0001124198 flr:AccumulatedOtherComprehensiveIncomeLossEquityMethodInvestmentsAttributableToNoncontrollingInterestMember 2021-12-31 0001124198 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentAttributableToNoncontrollingInterestMember 2021-12-31 0001124198 us-gaap:AccumulatedGainLossNetCashFlowHedgeNoncontrollingInterestMember 2021-12-31 0001124198 us-gaap:AociAttributableToNoncontrollingInterestMember 2021-12-31 0001124198 us-gaap:AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember 2022-01-01 2022-03-31 0001124198 flr:AccumulatedOtherComprehensiveIncomeLossEquityMethodInvestmentsAttributableToNoncontrollingInterestMember 2022-01-01 2022-03-31 0001124198 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentAttributableToNoncontrollingInterestMember 2022-01-01 2022-03-31 0001124198 us-gaap:AccumulatedGainLossNetCashFlowHedgeNoncontrollingInterestMember 2022-01-01 2022-03-31 0001124198 us-gaap:AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember 2022-03-31 0001124198 flr:AccumulatedOtherComprehensiveIncomeLossEquityMethodInvestmentsAttributableToNoncontrollingInterestMember 2022-03-31 0001124198 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentAttributableToNoncontrollingInterestMember 2022-03-31 0001124198 us-gaap:AccumulatedGainLossNetCashFlowHedgeNoncontrollingInterestMember 2022-03-31 0001124198 us-gaap:AociAttributableToNoncontrollingInterestMember 2022-03-31 0001124198 flr:AccumulatedOtherComprehensiveIncomeLossEquityMethodInvestmentsMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001124198 flr:AccumulatedOtherComprehensiveIncomeLossEquityMethodInvestmentsMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0001124198 flr:CommodityContractAndForeignExchangeContractMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001124198 flr:CommodityContractAndForeignExchangeContractMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0001124198 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001124198 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31
Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2023
Or
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission File Number: 1-16129
FLUOR CORPORATION
(Exact name of registrant as specified in its charter)

Delaware |  | 33-0927079
(State or other jurisdiction of |  | (I.R.S. Employer
incorporation or organization) |  | Identification No.)
6700 Las Colinas Boulevard |  |
Irving, | Texas |  | 75039
(Address of principal executive offices) |  | (Zip Code)

469-398-7000
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class | Trading Symbol(s) | Name of Each Exchange on Which Registered
Common Stock, $.01 par value per share | FLR | New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý No o
Indicate by check mark whether the registrant has submitted electronically, if any, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ý No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer | ☒ | Accelerated filer | ☐
Non-accelerated filer | ☐ | Smaller reporting company | ☐
|  | Emerging growth company | ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ý
As of April 28, 2023, 143,237,347 shares of the registrant’s common stock, $0.01 par value, were outstanding.

Table of Contents
FLUOR CORPORATION
FORM 10-Q

TABLE OF CONTENTS | PAGE
| Glossary of Terms | 2
Part I: | Financial Information |
| Item 1: | Condensed C onsolidated Financial Statement s (Unaudited) |
|  | Statement of Operations | 3
|  | Statement of Comprehensive Income (Loss) | 4
|  | Balance Shee t | 5
|  | Statement of Cash Flows | 6
|  | Statement of Changes in Equity | 7
|  | Notes to Financial Statements | 8
| Item 2: | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 20
| Item 3: | Quantitative and Qualitative Disclosures about Market Risk | 28
| Item 4: | Controls and Procedures | 28
| Changes in Consolidated Backlog (Unaudited) | 29
Part II: | Other Information |
| Item 1: | Legal Proceedings | 30
| Item 1A: | Risk Factors | 30
| Item 2: | Unregistered Sales of Equity Securities and Use of Proceeds | 30
| Item 4: | Mine Safety Disclosures | 30
| Item 6: | Exhibits | 31
Signatures |  | 32

1

Table of Contents
Glossary of Terms
The definitions and abbreviations set forth below apply to the indicated terms used throughout this filing.

Abbreviation/Term | Definition
2022 10-K | Annual Report on Form 10-K for the year ended December 31, 2022
2022 Quarter | Three months ended March 31, 2022
2023 Quarter | Three months ended March 31, 2023
3ME | Three months ended
AMECO | American Equipment Company, Inc.
AOCI | Accumulated other comprehensive income (loss)
APIC | Additional paid-in capital
ASC | Accounting Standards Codification
ASU | Accounting Standards Update
CFM | Customer-furnished materials
COVID | Coronavirus pandemic
CPS | Convertible preferred stock
CTA | Currency translation adjustment
DB plan | Defined benefit pension plan
DOE | U.S. Department of Energy
DOJ | U.S. Department of Justice
EPC | Engineering, procurement and construction
EPS | Earnings (loss) per share
Exchange Act | Securities Exchange Act of 1934
Fluor | Fluor Corporation and subsidiaries
G&A | General and administrative expense
GAAP | Accounting principles generally accepted in the United States
ICFR | Internal control over financial reporting
IT | Information technology
LNG | Liquefied natural gas
NCI | Noncontrolling interests
NM | Not meaningful
NRC | U.S. Nuclear Regulatory Commission
NuScale | NuScale Power Corporation
OCI | Other comprehensive income (loss)
PP&E | Property, plant and equipment
RSU | Restricted stock units
RUPO | Remaining unsatisfied performance obligations
SEC | Securities and Exchange Commission
SGI | Stock growth incentive awards
SMR | Small modular reactor
Stork | Stork Holding B.V. and subsidiaries
TSR | Total shareholder return
VIE | Variable interest entity

2

Table of Contents
PART I: FINANCIAL INFORMATION
FLUOR CORPORATION
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS
UNAUDITED

|  | 3ME March 31,
(in millions, except per share amounts) |  | 2023 |  | 2022
Revenue |  | $ | 3,752 |  |  | $ | 3,122 |
Cost of revenue |  | (3,790) |  |  | (2,999) |
Gross profit (loss) |  | (38) |  |  | 123 |
G&A |  | (62) |  |  | (71) |
Impairment |  | — |  |  | 63 |
Foreign currency loss |  | (41) |  |  | (19) |
Operating profit (loss) |  | (141) |  |  | 96 |
Interest expense |  | (16) |  |  | (16) |
Interest income |  | 57 |  |  | 7 |
Earnings (loss) before taxes |  | (100) |  |  | 87 |
Income tax expense |  | (30) |  |  | (31) |
Net earnings (loss) |  | (130) |  |  | 56 |
Less: Net earnings (loss) attributable to NCI |  | (23) |  |  | 8 |
Net earnings (loss) attributable to Fluor |  | $ | (107) |  |  | $ | 48 |
Less: Dividends on CPS |  | 10 |  |  | 10 |
Net earnings (loss) available to Fluor common stockholders |  | $ | (117) |  |  | $ | 38 |
Basic EPS available to Fluor common stockholders |  | $ | (0.82) |  |  | $ | 0.27 |
Diluted EPS available to Fluor common stockholders |  | $ | (0.82) |  |  | $ | 0.27 |

The accompanying notes are an integral part of these financial statements.
3

Table of Contents
FLUOR CORPORATION
CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (LOSS)
UNAUDITED

|  | 3ME March 31,
(in millions) |  | 2023 |  | 2022
Net earnings (loss) |  | $ | (130) |  |  | $ | 56 |
OCI, net of tax: |  |  |  |
Foreign currency translation adjustment |  | 46 |  |  | 29 |
Ownership share of equity method investees’ OCI |  | (1) |  |  | 1 |
DB plan adjustments |  | 1 |  |  | 1 |
Unrealized gain (loss) on hedges |  | — |  |  | (2) |
Total OCI, net of tax |  | 46 |  |  | 29 |
Comprehensive income (loss) |  | (84) |  |  | 85 |
Less: Comprehensive income (loss) attributable to NCI |  | (23) |  |  | 8 |
Comprehensive income (loss) attributable to Fluor |  | $ | (61) |  |  | $ | 77 |

The accompanying notes are an integral part of these financial statements.
4

Table of Contents
FLUOR CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEET
UNAUDITED

(in millions, except share and per share amounts) |  | March 31, 2023 |  | December 31, 2022
ASSETS
Current assets |  |  |  |
Cash and cash equivalents ($642 and $706 related to VIEs) |  | $ | 2,137 |  |  | $ | 2,439 |
Marketable securities ($132 and $130 related to VIEs) |  | 174 |  |  | 185 |
Accounts receivable, net ($149 and $196 related to VIEs) |  | 1,088 |  |  | 1,109 |
Contract assets ($172 and $186 related to VIEs) |  | 1,063 |  |  | 915 |
Other current assets ($25 and $30 related to VIEs) |  | 375 |  |  | 396 |
Total current assets |  | 4,837 |  |  | 5,044 |
Noncurrent assets |  |  |  |
PP&E, net ($44 and $45 related to VIEs) |  | 434 |  |  | 447 |
Investments |  | 612 |  |  | 584 |
Deferred taxes |  | 34 |  |  | 34 |
Deferred compensation trusts |  | 226 |  |  | 234 |
Goodwill |  | 206 |  |  | 206 |
Other assets ($77 and $54 related to VIEs) |  | 281 |  |  | 278 |
Total noncurrent assets |  | 1,793 |  |  | 1,783 |
Total assets |  | $ | 6,630 |  |  | $ | 6,827 |
LIABILITIES AND EQUITY
Current liabilities |  |  |  |
Accounts payable ($240 and $253 related to VIEs) |  | $ | 1,068 |  |  | $ | 1,017 |
Short-term debt and current portion of long-term debt |  | 16 |  |  | 152 |
Contract liabilities ($380 and $352 related to VIEs) |  | 765 |  |  | 742 |
Accrued salaries, wages and benefits ($22 and $24 related to VIEs) |  | 574 |  |  | 626 |
Other accrued liabilities ($46 related to VIEs in both periods) |  | 743 |  |  | 679 |
Total current liabilities |  | 3,166 |  |  | 3,216 |
Long-term debt |  | 978 |  |  | 978 |
Deferred taxes |  | 84 |  |  | 73 |
Other noncurrent liabilities ($43 and $54 related to VIEs) |  | 495 |  |  | 564 |
Commitments and contingencies |  |  |  |
Equity |  |  |  |
Shareholders’ equity |  |  |  |
Preferred stock — authorized 20,000,000 shares ($0.01 par value); issued and outstanding —600,000 shares in 2023 and 2022 |  | — |  |  | — |
Common stock — authorized 375,000,000 shares ($0.01 par value); issued and outstanding — 143,237,347 and 142,322,247 shares in 2023 and 2022, respectively |  | 1 |  |  | 1 |
APIC |  | 1,257 |  |  | 1,254 |
AOCI |  | (319) |  |  | (365) |
Retained earnings |  | 780 |  |  | 896 |
Total shareholders’ equity |  | 1,719 |  |  | 1,786 |
NCI |  | 188 |  |  | 210 |
Total equity |  | 1,907 |  |  | 1,996 |
Total liabilities and equity |  | $ | 6,630 |  |  | $ | 6,827 |

The accompanying notes are an integral part of these financial statements.
5

Table of Contents
FLUOR CORPORATION
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
UNAUDITED

|  | 3ME March 31,
(in millions) |  | 2023 |  | 2022
OPERATING CASH FLOW |  |  |  |
Net earnings (loss) |  | $ | (130) |  |  | $ | 56 |
Adjustments to reconcile net earnings to operating cash flow: |  |  |  |
Impairment |  | — |  |  | (63) |
Depreciation and amortization |  | 18 |  |  | 15 |
(Earnings) loss from equity method investments, net of distributions |  | — |  |  | (3) |
Loss (gain) on sales of assets (including AMECO-South America in 2023) |  | 58 |  |  | — |
Stock-based compensation |  | 16 |  |  | 13 |
Deferred taxes |  | 12 |  |  | 1 |
Changes in assets and liabilities |  | (133) |  |  | (203) |
Other |  | (2) |  |  | (4) |
Operating cash flow |  | (161) |  |  | (188) |
INVESTING CASH FLOW |  |  |  |
Purchases of marketable securities |  | (71) |  |  | (158) |
Proceeds from the sales and maturities of marketable securities |  | 82 |  |  | 82 |
Capital expenditures |  | (20) |  |  | (10) |
Proceeds from sales of assets (including AMECO-South America in 2023) |  | 22 |  |  | 3 |
Investments in partnerships and joint ventures |  | (2) |  |  | (24) |
Other |  | 2 |  |  | 2 |
Investing cash flow |  | 13 |  |  | (105) |
FINANCING CASH FLOW |  |  |  |
Purchases and retirement of debt |  | (137) |  |  | — |
Dividends paid on CPS |  | (10) |  |  | (10) |
Other borrowings (debt repayments) |  | 2 |  |  | 7 |
Distributions paid to NCI |  | — |  |  | (7) |
Capital contributions by NCI |  | 1 |  |  | — |
Taxes paid on vested restricted stock |  | (10) |  |  | (5) |
Other |  | (7) |  |  | (1) |
Financing cash flow |  | (161) |  |  | (16) |
Effect of exchange rate changes on cash |  | 7 |  |  | 13 |
Increase (decrease) in cash and cash equivalents |  | (302) |  |  | (296) |
Cash and cash equivalents at beginning of period |  | 2,439 |  |  | 2,209 |
Cash and cash equivalents at end of period |  | $ | 2,137 |  |  | $ | 1,913 |
SUPPLEMENTAL INFORMATION: |  |  |  |
Cash paid for interest |  | $ | 19 |  |  | $ | 20 |
Cash paid for income taxes (net of refunds) |  | 24 |  |  | 14 |

The accompanying notes are an integral part of these financial statements.
6

Table of Contents
FLUOR CORPORATION
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
UNAUDITED

(in millions, except per share amounts) | Preferred Stock | Common Stock | APIC | AOCI | Retained Earnings | Total Shareholders' Equity | NCI | Total Equity
Shares | Amount | Shares | Amount
BALANCE AS OF DECEMBER 31, 2022 | 1 |  | $ | — |  | 142 |  | $ | 1 |  | $ | 1,254 |  | $ | (365) |  | $ | 896 |  | $ | 1,786 |  | $ | 210 |  | $ | 1,996 |
Net earnings (loss) | — |  | — |  | — |  | — |  | — |  | — |  | (107) |  | (107) |  | (23) |  | (130) |
OCI | — |  | — |  | — |  | — |  | — |  | 46 |  | — |  | 46 |  | — |  | 46 |
Capital contributions by NCI | — |  | — |  | — |  | — |  | — |  | — |  | — |  | — |  | 1 |  | 1 |
Other NCI transactions | — |  | — |  | — |  | — |  | 2 |  | — |  | — |  | 2 |  | — |  | 2 |
Stock-based compensation | — |  | — |  | 1 |  | — |  | 1 |  | — |  | (9) |  | (8) |  | — |  | (8) |
BALANCE AS OF MARCH 31, 2023 | 1 |  | $ | — |  | 143 |  | $ | 1 |  | $ | 1,257 |  | $ | (319) |  | $ | 780 |  | $ | 1,719 |  | $ | 188 |  | $ | 1,907 |

(in millions, except per share amounts) | Preferred Stock | Common Stock | APIC | AOCI | Retained Earnings | Total Shareholders' Equity | NCI | Total Equity
Shares | Amount | Shares | Amount
BALANCE AS OF DECEMBER 31, 2021 | 1 |  | $ | — |  | 141 |  | $ | 1 |  | $ | 967 |  | $ | (366) |  | $ | 791 |  | $ | 1,393 |  | $ | 174 |  | $ | 1,567 |
Net earnings (loss) | — |  | — |  | — |  | — |  | — |  | — |  | 48 |  | 48 |  | 8 |  | 56 |
OCI | — |  | — |  | — |  | — |  | — |  | 29 |  | — |  | 29 |  | — |  | 29 |
Distributions to NCI, net of capital contributions | — |  | — |  | — |  | — |  | — |  | — |  | — |  | — |  | (7) |  | (7) |
Other NCI transactions | — |  | — |  | — |  | — |  | 1 |  | — |  | — |  | 1 |  | 1 |  | 2 |
Stock-based compensation | — |  | — |  | 1 |  | — |  | 8 |  | — |  | (10) |  | (2) |  | — |  | (2) |
BALANCE AS OF MARCH 31, 2022 | 1 |  | $ | — |  | 142 |  | $ | 1 |  | $ | 976 |  | $ | (337) |  | $ | 829 |  | $ | 1,469 |  | $ | 176 |  | $ | 1,645 |

The accompanying notes are an integral part of these financial statements.
7

Table of Contents
FLUOR CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
UNAUDITED
1. Principles of Consolidation
These financial statements do not include footnotes and certain financial information presented annually under GAAP, and therefore, should be read in conjunction with our 2022 10-K. Accounting measurements at interim dates inherently involve greater reliance on estimates than at year-end. Although such estimates are based on management’s most recent assessment of the underlying facts and circumstances utilizing the most current information available, our reported results of operations may not necessarily be indicative of results that we expect for the full year.
The financial statements included herein are unaudited. We believe they contain all adjustments of a normal recurring nature which are necessary to present fairly our financial position and our operating results as of and for the periods presented. All significant intercompany transactions of consolidated subsidiaries are eliminated. Certain amounts in tables may not total or agree back to the financial statements due to immaterial rounding differences. Management has evaluated all material events occurring subsequent to March 31, 2023 through the filing date of this Q1 2023 10-Q.
Quarters are typically 13 weeks in length but, due to our December 31 year-end, the number of weeks in a reporting period may vary slightly during the year and for comparable prior year periods. We report our quarterly results of operations based on periods ending on the Sunday nearest March 31, June 30 and September 30, allowing for 13-week interim reporting periods. For clarity of presentation, all periods are labeled as if the periods ended on March 31, June 30 and September 30.
2. Recent Accounting Pronouncements
We did not implement any new accounting pronouncements during the 2023 Quarter. However, we are evaluating the impact of the future disclosures that may arise under recent SEC and other promulgators' proposals.
3. Earnings Per Share
Potentially dilutive securities include CPS, stock options, RSUs and performance-based award units. Diluted EPS reflects the assumed exercise or conversion of all dilutive securities using the if-converted and treasury stock methods. In computing diluted EPS, only securities that are actually dilutive are included.

|  | 3ME March 31,
(in millions, except per share amounts) |  | 2023 |  | 2022
Net earnings (loss) attributable to Fluor |  | $ | (107) |  |  | $ | 48 |
Less: Dividends on CPS |  | 10 |  |  | 10 |
Net earnings (loss) available to Fluor common stockholders |  | (117) |  |  | 38 |
Weighted average common shares outstanding |  | 142 |  |  | 142 |
Dilutive effect: |  |  |  |
CPS |  | — |  | —
Stock options, RSUs and performance-based award units |  | — |  | 2
Weighted average diluted shares outstanding |  | 142 |  |  | 144 |
Basic EPS available to Fluor common stockholders |  | $ | (0.82) |  |  | $ | 0.27 |
Diluted EPS available to Fluor common stockholders |  | $ | (0.82) |  |  | $ | 0.27 |
Anti-dilutive securities not included in shares outstanding: |  |  |  |
CPS |  | 27 |  |  | 27 |
Stock options, RSUs and performance-based award units |  | 5 |  |  | 3 |

8

Table of Contents
FLUOR CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
UNAUDITED
4. Operating Information by Segment and Geographic Area
We have decided to retain Stork's North American operations, which largely consists of our operations and maintenance business owned by Fluor prior to our acquisition of Stork. Beginning in the 2023 Quarter, this business line, renamed Plant & Facility Services, is included in our Urban Solutions segment for all periods presented.

|  | 3ME March 31,
(in millions) |  | 2023 |  | 2022
Revenue |  |  |  |
Energy Solutions |  | $ | 1,612 |  |  | $ | 1,174 |
Urban Solutions |  | 1,208 |  |  | 1,061 |
Mission Solutions |  | 649 |  |  | 593 |
Other |  | 283 |  |  | 294 |
Total revenue |  | $ | 3,752 |  |  | $ | 3,122 |
Segment profit (loss) |  |  |  |
Energy Solutions |  | $ | 88 |  |  | $ | 54 |
Urban Solutions |  | (20) |  |  | 17 |
Mission Solutions |  | 7 |  |  | 58 |
Other |  | (90) |  |  | (14) |
Total segment profit (loss) |  | $ | (15) |  |  | $ | 115 |
G&A |  | (62) |  |  | (71) |
Impairment |  | — |  |  | 63 |
Foreign currency loss |  | (41) |  |  | (19) |
Interest income (expense), net |  | 41 |  |  | (9) |
Earnings (loss) attributable to NCI |  | (23) |  |  | 8 |
Earnings (loss) before taxes |  | $ | (100) |  |  | $ | 87 |

Energy Solutions. Segment profit in the 2023 Quarter included a favorable foreign currency remeasurement effect totaling $22 million (or $0.09 per share) on a project with multiple currencies. Segment profit in the 2023 Quarter and 2022 Quarter included expense of $39 million and $13 million, respectively, related to embedded foreign currency derivatives.
Urban Solutions. Segment profit in the 2023 Quarter included a $59 million (or $0.34 per share) charge for rework associated with subcontractor design errors, related schedule impacts and system integration testing timelines on the LAX Automated People Mover project. Intercompany revenue for our professional staffing business, excluded from the amounts shown above, was $69 million and $60 million for the 2023 Quarter and 2022 Quarter, respectively.
Mission Solutions. Segment profit in the 2023 Quarter included a $21 million (or $0.12 per share) charge for cost growth resulting from government directed change orders and the associated schedule delays on a weapons facility project.
Other. Segment profit (loss) for NuScale, Stork and AMECO follows:

| 3ME March 31,
(in millions) | 2023 |  | 2022
NuScale(1) | $ | (29) |  |  | $ | (21) |
Stork | 1 |  |  | 4 |
AMECO | (62) |  |  | 3 |
Segment profit (loss) | $ | (90) |  |  | $ | (14) |

(1) As of March 31, 2023, we had an approximate 56% ownership in NuScale.
9

Table of Contents
FLUOR CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
UNAUDITED
In March 2023, we sold our AMECO South America business, which included operations in Chile and Peru. This transaction marks the completion of the AMECO divestiture for total proceeds of $144 million, including $17 million during the 2023 Quarter. Previous AMECO divestitures included assets in Africa, the Caribbean, Mexico and North America. Upon the sale of AMECO South America in the 2023 Quarter, we recognized a $60 million negative earnings impact, including $35 million for foreign currency translation.
Total assets by segment are as follows:

(in millions) |  | March 31, 2023 |  | December 31, 2022
Energy Solutions |  | $ | 1,021 |  |  | $ | 967 |
Urban Solutions |  | 1,215 |  |  | 1,170 |
Mission Solutions |  | 572 |  |  | 485 |
Other |  | 516 |  |  | 583 |
Corporate |  | 3,306 |  |  | 3,622 |
Total assets |  | $ | 6,630 |  |  | $ | 6,827 |

Revenue by project location follows:

|  | 3ME March 31,
(in millions) |  | 2023 |  | 2022
North America |  | $ | 2,651 |  |  | $ | 1,908 |
Asia Pacific (including Australia) |  | 324 |  |  | 249 |
Europe |  | 512 |  |  | 549 |
Central and South America |  | 221 |  |  | 351 |
Middle East and Africa |  | 44 |  |  | 65 |
Total revenue |  | $ | 3,752 |  |  | $ | 3,122 |

5. Impairment
We did not recognize any material impairment expense during the 2023 Quarter. During the 2022 Quarter, we reversed $63 million in impairment originally recognized in 2021 when our Stork and AMECO businesses were classified as held for sale due primarily to remeasurement under held and used impairment criteria, for which CTA balances are excluded from carrying value.
10

Table of Contents
FLUOR CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
UNAUDITED
6. Income Taxes
The effective tax rate on earnings for the 2023 Quarter was (30.1)% compared to 35.4% for the 2022 Quarter. A reconciliation of U.S. statutory federal income tax expense to income tax expense follows:

| 3ME March 31
(In millions) | 2023 |  | 2022
U.S. statutory federal tax expense (benefit) | $ | (21) |  |  | $ | 18 |
Increase (decrease) in taxes resulting from: |  |  |
State and local income taxes, net of federal income tax effects | (3) |  |  | 1 |
Valuation allowance | 52 |  |  | 16 |
Foreign tax effects | 8 |  |  | 2 |
Noncontrolling interest | 5 |  |  | (2) |
Sale of AMECO South America | (10) |  |  | — |
Other adjustments | (1) |  |  | (4) |
Total income tax expense | $ | 30 |  |  | $ | 31 |

7. Partnerships and Joint Ventures
Many of our partnership and joint venture agreements provide for capital calls to fund operations, as necessary. Investments in a loss position of $379 million and $312 million were included in other accrued liabilities as of March 31, 2023 and December 31, 2022, respectively, and consisted primarily of provision for anticipated losses on legacy infrastructure projects. Accounts receivable related to work performed for unconsolidated partnerships and joint ventures included in “Accounts receivable, net” was $190 million and $185 million as of March 31, 2023 and December 31, 2022, respectively.
Variable Interest Entities
The aggregate carrying value of unconsolidated VIEs (classified under both "Investments” and “Other accrued liabilities”) was a net liability of $14 million as of March 31, 2023 and a net asset of $46 million as of December 31, 2022. Some of our VIEs have debt; however, such debt is typically non-recourse to us. Our maximum exposure to loss as a result of our investments in unconsolidated VIEs is typically limited to the aggregate of the carrying value of the investment and future funding necessary to satisfy the contractual obligations of the VIE. Future funding commitments as of March 31, 2023 for the unconsolidated VIEs were $57 million.
We are required to consolidate certain VIEs. Assets and liabilities associated with the operations of our consolidated VIEs are presented on the balance sheet. The assets of a VIE are restricted for use only for the particular VIE and are not available for our general operations. We have agreements with certain VIEs to provide financial or performance assurances to clients, as discussed elsewhere.
8. Guarantees
The maximum potential amount of future payments that we could be required to make under outstanding performance guarantees, which represents the remaining cost of work to be performed, was estimated to be $15 billion as of March 31, 2023. For cost reimbursable contracts, amounts that may become payable pursuant to guarantee provisions are normally recoverable from the client for work performed. For lump-sum contracts, the performance guarantee amount is the cost to complete the contracted work, less amounts remaining to be billed to the client under the contract. Remaining billable amounts could be greater or less than the cost to complete. In those cases where costs exceed the remaining amounts payable under the contract, we may have recourse to third parties, such as owners, partners, subcontractors or vendors for claims. The performance guarantee obligation was not material as of March 31, 2023 and December 31, 2022.
11

Table of Contents
FLUOR CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
UNAUDITED
9. Commitments and Contingencies
We and certain of our subsidiaries are subject to litigation, claims and other commitments and contingencies, including matters arising in the ordinary course of business, of which the asserted value may be significant. We record accruals in the financial statements for pending legal matters when we determine that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. While it is reasonably possible that a loss may be incurred in any of the matters identified below, including a loss in excess of amounts accrued, management is unable to estimate the possible loss or range of loss or has determined such amounts to be immaterial. At present, except as set forth below, we do not expect that the ultimate resolution of any open matters will have a material adverse effect on our financial position or results of operations. However, legal proceedings and regulatory and governmental matters are subject to inherent uncertainties, and unfavorable rulings or other events could occur. Unfavorable outcomes could involve substantial monetary damages, fines, penalties and other expenditures. An unfavorable outcome might result in a material adverse impact on our business, results of operations or financial position. We might also enter into an agreement to settle one or more such matters if we determine such settlement is in the best interests of our stakeholders, and any such settlement could include substantial payments.
The following disclosures for commitments and contingencies have been updated since the matter was presented in the 2022 10-K.
Fluor Australia Ltd., our wholly-owned subsidiary (“Fluor Australia”), completed a cost reimbursable engineering, procurement and construction management services project for Santos Ltd. (“Santos”) involving a large network of natural gas gathering and processing facilities in Queensland, Australia. On December 13, 2016, Santos filed an action in Queensland Supreme Court (the “Court”) against Fluor Australia, asserting various causes of action and seeking damages and/or a refund of contract proceeds paid of AUD $1.47 billion. Santos has joined Fluor to the matter on the basis of a parent company guarantee issued for the project. In March 2023, a panel of three referees appointed by the Court (the "Panel”) issued a draft, non-binding report setting forth recommendations to the Court regarding liability and damages in the lawsuit. When finalized, the Panel’s report has no legal effect unless it is adopted by the Court through an adoption hearing, and the Court can accept or reject, in whole or in part, the Panel’s recommendations. In the draft report, the Panel recommended judgment for Fluor on one of Santos’s damages claims that Santos contends has an approximate value of AUD $700 million, and recommended judgment for Santos on other claims that Santos contends have a roughly equivalent damages value (although the Panel has not yet recommended a precise amount of damages with respect to these claims and the amount of any damages is the subject of further submissions to the Panel). While the project contract contains a liability cap of approximately AUD $236 million, the Panel found that the liability cap did not apply to Santos’s claims. The Panel is expected to issue a final report later in 2023, after which the Court is expected to schedule an adoption hearing. In parallel with further action by the Panel, Fluor has submitted an application to have the Court set aside the reference to the Panel and the Panel’s recommendations on several procedural and substantive grounds, including its failure to apply the project contract’s liability cap. That application is expected to be heard in the third quarter of 2023.
Since September 2018, eleven separate purported shareholders' derivative actions were filed against current and former members of the Board of Directors, as well as certain of Fluor’s current and former executives. Fluor is named as a nominal defendant in the actions. These derivative actions purport to assert claims on behalf of Fluor and make substantially the same factual allegations as the securities class action matter which was resolved in 2022, as previously disclosed in our 2022 10-K, and seek various forms of monetary and injunctive relief. These actions are pending in Texas state court (District Court for Dallas County), the U.S. District Court for the District of Delaware, the U.S. District Court for the Northern District of Texas, and the Court of Chancery of the State of Delaware. Certain of these actions were consolidated, and all of these matters are currently stayed. The parties have reached an agreement for a global settlement of these matters. The settlement is subject to court approval, and the parties anticipate seeking that approval from the U.S. District Court for the Northern District of Texas.
There have been no substantive changes to the disclosures for the following commitments and contingencies since the matter was presented in the 2022 10-K.
Fluor Limited, our wholly-owned subsidiary (“Fluor Limited”), and Fluor Arabia Limited, a partially-owned subsidiary (“Fluor Arabia”), completed cost reimbursable engineering, procurement and construction management services for Sadara Chemical Company (“Sadara”) involving a large petrochemical facility in Jubail, Kingdom of Saudi Arabia. On August 23, 2019, Fluor Limited and Fluor Arabia Limited commenced arbitration proceedings against Sadara after it refused to pay invoices totaling approximately $100 million due under the contracts. As part of the arbitration proceedings, Sadara has asserted various counterclaims for damages and/or a refund of contract proceeds paid totaling $574 million against Fluor Limited and Fluor Arabia Limited.
12

Table of Contents
FLUOR CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
UNAUDITED
Various wholly-owned subsidiaries of Fluor, in conjunction with a partner, TECHINT, (“Fluor/TECHINT”) performed engineering, procurement and construction management services on a cost reimbursable basis for Barrick Gold Corporation involving a gold mine and ore processing facility on a site straddling the border between Argentina and Chile. In 2013 Barrick terminated the Fluor/TECHINT agreements for convenience and not due to the performance of Fluor/TECHINT. On August 12, 2016, Barrick filed a notice of arbitration against Fluor/TECHINT, demanding damages and/or a refund of contract proceeds paid of not less than $250 million under various claims relating to Fluor/TECHINT’s alleged performance. Proceedings were suspended while the parties explored a possible settlement. In August 2019, Barrick drew down $36 million of letters of credit from Fluor/TECHINT ($24 million from Fluor and $12 million from TECHINT). Thereafter, Barrick proceeded to reactivate the arbitration. Barrick and Fluor/TECHINT exchanged detailed statements of claim and counterclaim pursuant to which Barrick's claim against Fluor/TECHINT totaled $364 million net of amounts acknowledged to be due to Fluor/TECHINT.
Fluor Enterprises Inc., our wholly-owned subsidiary, (“Fluor”) in conjunction with a partner, Balfour Beatty Infrastructure, Inc., (“Balfour”) formed a joint venture known as Prairie Link Constructors JV (“PLC”) and, through it, contracted with the North Texas Tollway Authority (“NTTA”) to provide design and build services in relation to the extension of the NTTA’s President George Bush Turnpike highway (“Project”). PLC completed the Project in 2012. In October 2022, the NTTA served PLC, Fluor and Balfour with a petition, filed at Dallas County Court, demanding damages of an unquantified amount under various claims relating to alleged breaches of contract and or negligence. In its initial disclosures as part of the litigation, the NTTA stated that its damages are expected to exceed $100 million and that damages will be calculated by experts and provided in the normal course of the litigation. We have answered the petition and asserted claims for, among other things, indemnity from subcontractors.
Other Matters
In February 2020, we announced that the SEC is conducting an investigation and requested documents and information related to projects for which we recorded charges in the second quarter of 2019. In April 2020 and January 2022, Fluor received subpoenas from the U.S. DOJ seeking documents and information related to the second quarter 2019 charges; certain of the projects associated with those charges; and certain project accounting, financial reporting and governance matters. These matters remain unresolved, and we have continued to cooperate and engage with the SEC and DOJ regarding these investigations including discussions with the SEC regarding the potential resolution of its investigation. Based upon our assessment in the fourth quarter of 2022, we recorded an accrual related to this matter, although no assurance can be given as to the ultimate outcome of these matters, and we are not able to predict whether any legal, regulatory or reputational impacts of any allegations or resolution of these matters will have a material impact on our results.
13

Table of Contents
FLUOR CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
UNAUDITED
10. Contract Assets and Liabilities
The following summarizes information about our contract assets and liabilities:

(in millions) | March 31, 2023 | December 31, 2022
Information about contract assets: |  |
Contract assets |  |
Unbilled receivables - reimbursable contracts | $ | 866 |  | $ | 738 |
Contract work in progress - lump-sum contracts | 197 |  | 177 |
Contract assets | $ | 1,063 |  | $ | 915 |
Advance billings deducted from contract assets | $ | 239 |  | $ | 220 |
| 3ME March 31,
(in millions) | 2023 | 2022
Information about contract liabilities: |  |
Revenue recognized that was included in contract liabilities as of January 1 | $ | 313 |  | $ | 531 |

We periodically evaluate our project forecasts and the amounts recognized with respect to our claims and unapproved change orders. We include estimated amounts for claims and unapproved change orders in project revenue to the extent it is probable we will realize those amounts. As of March 31, 2023 and December 31, 2022, we had recorded $526 million and $498 million, respectively, of revenue associated with claims and unapproved change orders for costs incurred to date. Additional costs, which will increase this balance over time, are expected to be incurred in future periods. We had no material disputed back charges to suppliers or subcontractors as of March 31, 2023 and December 31, 2022.
11. Remaining Unsatisfied Performance Obligations
We estimate that our RUPO will be satisfied over the following periods:

(in millions) | March 31, 2023
Within 1 year | $ | 13,056 |
1 to 2 years | 7,412 |
Thereafter | 3,890 |
Total RUPO | $ | 24,358 |

14

Table of Contents
FLUOR CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
UNAUDITED
12. Debt and Lines of Credit
Debt consisted of the following:

(in millions) | March 31, 2023 |  | December 31, 2022
Borrowings under credit facility | $ | — |  |  | $ | — |
Current: |  |  |
2023 Notes | $ | — |  |  | $ | 138 |
Other borrowings | 16 |  |  | 14 |
Total current | $ | 16 |  |  | $ | 152 |
Long-term: |  |  |
Senior Notes |  |  |
2024 Notes | 381 |  |  | $ | 381 |
Unamortized discount on 2024 Notes | (1) |  |  | (1) |
Unamortized deferred financing costs | — |  |  | — |
2028 Notes | 600 |  |  | 600 |
Unamortized discount on 2028 Notes | (1) |  |  | (1) |
Unamortized deferred financing costs | (3) |  |  | (3) |
Other long-term borrowings | 2 |  |  | 2 |
Total long-term | $ | 978 |  |  | $ | 978 |

Credit Facility
As of March 31, 2023, letters of credit totaling $420 million were outstanding under our $1.8 billion credit facility, which was amended in February 2023 to extend the maturity to February 2026. This credit facility contains customary financial covenants, including a debt-to-capitalization ratio that cannot exceed 0.60 to 1.00, a limitation on the aggregate amount of debt of the greater of $750 million or €750 million for our subsidiaries, and a minimum liquidity threshold of $1.1 billion, defined in the amended credit facility, which may be reduced to $1.0 billion upon the repayment of debt. The credit facility also contains provisions that will require us to provide collateral to secure the facility should we be downgraded to BB by S&P and Ba2 by Moody's, such collateral consisting broadly of our U.S. assets. Borrowings under the facility, which may be denominated in USD, EUR, GBP or CAD, bear interest at a base rate, plus an applicable borrowing margin. As of March 31, 2023, we had not made any borrowings under our credit line and maintained a borrowing capacity of $828 million.
Uncommitted Lines of Credit
As of March 31, 2023, letters of credit totaling $957 million were outstanding under uncommitted lines of credit.
Senior Notes
In January 2023, we redeemed the remaining €129 million of outstanding 2023 Notes for $140 million with no earnings impact.
13. Convertible Preferred Stock
First quarter CPS dividends of $10 million were paid in February 2023. In April 2023, our Board of Directors approved the payment of second quarter CPS dividends of $10 million, payable in May 2023.
Each share of CPS is convertible at the holder's option at any time into 44.9585 shares of our common stock per share of CPS. The conversion rate is subject to certain customary adjustments, but no payment or adjustment for accumulated but unpaid dividends will be made upon conversion, subject to certain limited exceptions. The CPS may not be redeemed by us; however, we are able, since May 20, 2022, to elect to cause all outstanding shares of CPS to be converted into shares of our common stock at the conversion rate, subject to certain conditions (and, if such conversion occurs prior to May 20, 2024, the payment of a cash make-whole premium). The most significant condition to our ability to invoke a conversion prior to May 2024 is the requirement that our common stock trade above $28.92 for 20 consecutive trading days, which occurred in the fourth quarter of 2022 and persisted through March 31, 2023. We estimate that the cash make-whole payment would have
15

Table of Contents
FLUOR CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
UNAUDITED
been $60 million (using the actual average 5-day trading price leading up to March 31, 2023). If a make-whole fundamental change, as defined in the certificate of designations for the CPS, occurs, we will in certain circumstances be required to increase the conversion rate for a holder who elects to convert shares of CPS in connection with such make-whole fundamental change.
14. Fair Value Measurements
The following table delineates assets and liabilities that are measured at fair value on a recurring basis:

|  | March 31, 2023 |  | December 31, 2022
|  | Fair Value Hierarchy |  | Fair Value Hierarchy
(in millions) |  | Total |  | Level 1 |  | Level 2 |  | Level 3 |  | Total |  | Level 1 |  | Level 2 |  | Level 3
Assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Deferred compensation trusts(1) |  | $ | 11 |  |  | $ | 11 |  |  | $ | — |  |  | $ | — |  |  | $ | 10 |  |  | $ | 10 |  |  | $ | — |  |  | $ | — |
Derivative assets(2) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Foreign currency |  | 8 |  |  | — |  |  | 8 |  |  | — |  |  | 9 |  |  | — |  |  | 9 |  |  | — |
Commodity |  | 2 |  |  | — |  |  | 2 |  |  | — |  |  | 4 |  |  | — |  |  | 4 |  |  | — |
Liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
SMR warrants(3) |  | $ | 29 |  |  | $ | 16 |  |  | $ | 13 |  |  | $ | — |  |  | $ | 38 |  |  | $ | 21 |  |  | $ | 17 |  |  | $ | — |
Derivative liabilities(2) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Foreign currency |  | $ | 7 |  |  | $ | — |  |  | $ | 7 |  |  | $ | — |  |  | 8 |  |  | — |  |  | 8 |  |  | — |
Commodity |  | 1 |  |  | — |  |  | 1 |  |  | — |  |  | 1 |  |  | — |  |  | 1 |  |  | — |

_________________________________________________________
(1) Consists of registered money market funds and an equity index fund. These investments, which are trading securities, represent the net asset value at the close of business of the period based on the last trade or official close of an active market or exchange.
(2) Foreign currency and commodity derivatives are estimated using pricing models with market-based inputs, which take into account the present value of estimated future cash flows.
(3) The SMR warrant liabilities are comprised of public and private placement warrants redeemable by SMR under certain conditions, both measured using the price of the public warrants. The private placement warrants are not publicly traded and have been classified as Level 2 measurements while the public warrants are classified as Level 1.
16

Table of Contents
FLUOR CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
UNAUDITED
We have measured assets and liabilities held for sale at fair value on a nonrecurring basis. The following summarizes information about financial instruments that are not required to be measured at fair value:

|  |  | March 31, 2023 |  | December 31, 2022
(in millions) | Fair Value Hierarchy |  | Carrying Value |  | Fair Value |  | Carrying Value |  | Fair Value
Assets: |  |  |  |  |  |  |  |  |
Cash(1) | Level 1 |  | $ | 1,226 |  |  | $ | 1,226 |  |  | $ | 1,262 |  |  | $ | 1,262 |
Cash equivalents(2) | Level 2 |  | 911 |  |  | 911 |  |  | 1,177 |  |  | 1,177 |
Marketable securities(2) | Level 2 |  | 174 |  |  | 174 |  |  | 185 |  |  | 185 |
Notes receivable, including noncurrent portion(3) | Level 3 |  | 9 |  |  | 9 |  |  | 9 |  |  | 9 |
Liabilities: |  |  |  |  |  |  |  |  |
2023 Senior Notes(4) | Level 2 |  | $ | — |  |  | $ | — |  |  | $ | 138 |  |  | $ | 138 |
2024 Senior Notes(4) | Level 2 |  | 380 |  |  | 372 |  |  | 380 |  |  | 370 |
2028 Senior Notes(4) | Level 2 |  | 596 |  |  | 554 |  |  | 596 |  |  | 545 |
Other borrowings, including noncurrent portion(5) | Level 2 |  | 18 |  |  | 18 |  |  | 16 |  |  | 16 |

_________________________________________________________
(1) Cash consists of bank deposits. Carrying amounts approximate fair value.
(2) The carrying amounts of these time deposits approximate fair value because of the short-term maturity of these instruments. Amortized cost is not materially different from the fair value.
(3) Notes receivable are carried at net realizable value which approximates fair value. Factors considered in determining the fair value include the credit worthiness of the borrower, current interest rates, the term of the note and any collateral pledged as security. Notes receivable are periodically assessed for impairment.
(4) The fair value of the Senior Notes was estimated based on the quoted market prices and Level 2 inputs.
(5) Other borrowings represent bank loans and other financing arrangements which mature within one year. The carrying amount of borrowings under these arrangements approximates fair value because of the short-term maturity.
15. Stock-Based Compensation
Equity Awards
Our executive and director stock-based compensation plans are described more fully in the 2022 10-K. In the 2023 and 2022 Quarters, RSUs totaling 383,974 and 367,380, respectively, were granted to executives at a weighted-average grant date fair value of $35.76 and $21.90 per share, respectively, and generally vest over three years.
Stock options for the purchase of 178,434 and 250,656 shares at a weighted-average exercise price of $35.76 and $21.90 per share were awarded to executives during the 2023 and 2022 Quarters, respectively. The options granted in 2023 and 2022 generally vest over three years and expire ten years after the grant date.
Performance-based award units totaling 274,755 were awarded to certain senior executives and all Section 16 officers during the 2023 Quarter and performance-based award units totaling 426,957 were awarded to Section 16 officers during the 2022 Quarter. These awards generally cliff vest after 3 years and contain annual performance conditions for each of the 3 years of the vesting period. Under GAAP, performance-based elements of such awards are not deemed granted until the performance targets have been established. The performance targets for each year are generally established in the first quarter. For awards granted under the 2023 performance plan, 80% of the award is earned based on achievement of earnings before taxes targets over three one-year periods and 20% of the award is earned based on our three-year cumulative TSR relative to companies in the S&P 500 on the date of the award. For the majority of awards, generally only one-third of the
17

Table of Contents
FLUOR CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
UNAUDITED
units awarded in any given year are deemed to be granted each year of the 3-year vesting periods. During 2023, the following units were granted based upon the establishment of performance targets:

| Performance-based Award Units Granted in 2023 | Weighted Average Grant Date Fair Value Per Share
2023 Performance Award Plan | 91,585 | $39.00
2022 Performance Award Plan | 142,319 | $35.87
2021 Performance Award Plan | 204,622 | $46.84

For awards granted under the 2023, 2022 and 2021 performance award plans, the number of units are adjusted at the end of each performance period based on achievement of certain performance targets and market conditions, as defined in the award agreements.
Liability Awards
SGI awards and performance-based awards for other executives vest and become payable at a rate of one-third of the total award each year.

|  | Location in Statement of Operations |  | 3ME March 31,
Compensation Expense (in millions) |  |  | 2023 | 2022
SGI awards |  | G&A |  | $ | 7 |  | $ | 10 |
Performance-based awards for other executives |  | G&A |  | 7 |  | 15 |

Liabilities (in millions) |  | Location on Balance Sheet | March 31, 2023 |  | December 31, 2022
SGI awards |  | Accrued salaries, wages and benefits and Other noncurrent liabilities | $ | 48 |  |  | $ | 92 |
Performance-based awards for other executives |  | Accrued salaries, wages and benefits and Other noncurrent liabilities | 16 |  |  | 15 |

16. Other Comprehensive Income (Loss)
The components of OCI follow:

|  | 3ME March 31, 2023 |  | 3ME March 31, 2022
(in millions) |  | Before-Tax Amount |  | Tax Benefit (Expense) |  | Net-of-Tax Amount |  | Before-Tax Amount |  | Tax Benefit (Expense) |  | Net-of-Tax Amount
OCI: |  |  |  |  |  |  |  |  |  |  |  |
Foreign currency translation adjustments |  | $ | 46 |  |  | $ | — |  |  | $ | 46 |  |  | $ | 29 |  |  | $ | — |  |  | $ | 29 |
Ownership share of equity method investees’ OCI |  | (1) |  |  | — |  |  | (1) |  |  | — |  |  | 1 |  |  | 1 |
DB plan adjustments |  | 1 |  |  | — |  |  | 1 |  |  | 1 |  |  | — |  |  | 1 |
Unrealized gain (loss) on hedges |  | — |  |  | — |  |  | — |  |  | (2) |  |  | — |  |  | (2) |
Total OCI |  | 46 |  |  | — |  |  | 46 |  |  | 28 |  |  | 1 |  |  | 29 |
Less: OCI attributable to NCI |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
OCI attributable to Fluor |  | $ | 46 |  |  | $ | — |  |  | $ | 46 |  |  | $ | 28 |  |  | $ | 1 |  |  | $ | 29 |

18

Table of Contents
FLUOR CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
UNAUDITED
The changes in AOCI balances follow:

(in millions) | Foreign Currency Translation |  | Ownership Share of Equity Method Investees’ OCI |  | DB Plans |  | Unrealized Gain (Loss) on Hedges |  | AOCI, Net
Attributable to Fluor: |  |  |  |  |  |  |  |  |
Balance as of December 31, 2022 | $ | (328) |  |  | $ | (25) |  |  | $ | (13) |  |  | $ | 1 |  |  | $ | (365) |
OCI before reclassifications | 11 |  |  | (1) |  |  | 1 |  |  | (1) |  |  | 11 |
Amounts reclassified from AOCI | 35 |  |  | — |  |  | — |  |  | 1 |  |  | 35 |
Net OCI | 46 |  |  | (1) |  |  | 1 |  |  | — |  |  | 46 |
Balance as of March 31, 2023 | $ | (282) |  |  | $ | (26) |  |  | $ | (12) |  |  | $ | 1 |  |  | $ | (319) |
Attributable to NCI: |  |  |  |  |  |  |  |  |
Balance as of December 31, 2022 | $ | (2) |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | (2) |
OCI before reclassifications | — |  |  | — |  |  | — |  |  | — |  |  | — |
Amounts reclassified from AOCI | — |  |  | — |  |  | — |  |  | — |  |  | — |
Net OCI | — |  |  | — |  |  | — |  |  | — |  |  | — |
Balance as of March 31, 2023 | $ | (2) |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | (2) |
Attributable to Fluor: |  |  |  |  |  |  |  |  |
Balance as of December 31, 2021 | $ | (300) |  |  | $ | (56) |  |  | $ | (18) |  |  | $ | 8 |  |  | $ | (366) |
OCI before reclassifications | 29 |  |  | 1 |  |  | 1 |  |  | 2 |  |  | 33 |
Amounts reclassified from AOCI | — |  |  | — |  |  | — |  |  | (4) |  |  | (4) |
Net OCI | 29 |  |  | 1 |  |  | 1 |  |  | (2) |  |  | 29 |
Balance as of March 31, 2022 | $ | (271) |  |  | $ | (55) |  |  | $ | (17) |  |  | $ | 6 |  |  | $ | (337) |
Attributable to NCI: |  |  |  |  |  |  |  |  |
Balance as of December 31, 2021 | $ | (3) |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | (3) |
OCI before reclassifications | — |  |  | — |  |  | — |  |  | — |  |  | — |
Amounts reclassified from AOCI | — |  |  | — |  |  | — |  |  | — |  |  | — |
Net OCI | — |  |  | — |  |  | — |  |  | — |  |  | — |
Balance as of March 31, 2022 | $ | (3) |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | (3) |

The reclassifications out of AOCI follow:

|  | Location in Statement of Operations |  | 3ME March 31,
(in thousands) |  |  | 2023 |  | 2022
Component of AOCI: |  |  |  |  |  |
Foreign currency translation adjustment |  | Cost of revenue |  | $ | (35) |  |  | $ | — |
Income tax benefit |  | Income tax expense (benefit) |  | — |  |  | — |
Net of tax |  |  |  | $ | (35) |  |  | $ | — |
Unrealized gain (loss) on derivative contracts: |  |  |  |  |  |
Foreign currency contracts |  | Cost of revenue |  | $ | (1) |  |  | $ | 5 |
Income tax expense |  | Income tax expense (benefit) |  | — |  |  | (1) |
Net of tax |  |  |  | $ | (1) |  |  | $ | 4 |

19

Table of Contents
FLUOR CORPORATION
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis should be read in conjunction with our financial statements and our 2022 10-K. Except as the context otherwise requires, the terms Fluor or the Registrant, as used herein, are references to Fluor and references to the company, we, us, or our, as used herein, shall include Fluor, its consolidated subsidiaries and joint ventures.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
Certain statements made herein, including statements regarding our projected operating results, liquidity and backlog levels and the implementation of strategic initiatives are forward-looking in nature. Under the Private Securities Litigation Reform Act of 1995, a “safe harbor” may be provided to us for certain of these forward-looking statements. We caution readers that forward-looking statements, including disclosures which use words such as we “believe,” “anticipate,” “expect,” “estimate,” "aspire," "commit," "will," "may" and similar statements, are subject to risks and uncertainties which could cause actual results to differ materially from stated expectations. Significant factors potentially contributing to such differences include:
•The cyclical nature of many of the markets we serve and our clients' vulnerability to poor economic conditions, such as inflation, slow growth or recessions, which may result in decreased capital investment and reduced demand for our services;
•Our failure to receive anticipated new contract awards and the related impact on our operations;
•Failure to accurately estimate the cost and schedule on our projects, potentially resulting in cost overruns or obligations, including those related to project delays and those caused by the performance of our clients, subcontractors, suppliers and partners;
•Intense competition in the global EPC industry, which can place downward pressure on our contract prices and profit margins and may increase our contractual risks;
•The inability to hire and retain qualified personnel;
•Failure of our joint venture partners to perform their venture obligations, which could impact the success of those ventures and impose additional financial and performance obligations on us;
•Failure of our suppliers or subcontractors to provide supplies or services at the agreed-upon levels or times;
•Cybersecurity breaches of our systems and information technology;
•Civil unrest, security issues, labor conditions and other unforeseeable events in the countries in which we do business;
•Project cancellations, scope adjustments or deferrals, or foreign currency fluctuations, that could reduce the amount of our backlog and the revenue and profits that we earn;
•Repercussions of events beyond our control, such as severe weather conditions, natural disasters, pandemics, political crises or other catastrophic events, that may significantly affect operations, result in higher cost or subject the company to contract claims by our clients;
•Differences between our actual results and the assumptions and estimates used to prepare our financial statements;
•Client delays or defaults in making payments;
•The potential impact of changes in tax laws and other tax matters including, but not limited to, those from foreign operations, the realizability of our deferred tax assets and the ongoing audits by tax authorities;
•Our ability to secure appropriate insurance;
•The loss of business from one or more significant clients;
•The inability to adequately protect our intellectual property rights;
•The availability of credit and financial assurances plus restrictions imposed by credit facilities, both for us and our clients, suppliers, subcontractors or other partners;
•Adverse results in existing or future litigation, regulatory proceedings or dispute resolution proceedings (including claims for indemnification), or claims against project owners, subcontractors or suppliers;
•Failure of our employees, agents or partners to comply with laws, which could result in harm to our reputation and reduced profits or losses;
•The impact of new or changing legal requirements, as well as past and future environmental, health and safety regulations including climate change regulations; and
•The risks associated with acquisitions, dispositions or other investments, including the failure to successfully integrate acquired businesses.
Any forward-looking statements that we may make are based on our current expectations and beliefs concerning future developments and their potential effects on us. There is no assurance that future developments affecting us will be those presently anticipated by us.
20

Table of Contents
Additional information concerning these and other factors can be found in our press releases and periodic filings with the SEC, including the 2022 10-K. These filings are available publicly on the SEC’s website at http://www.sec.gov, on our website at http://investor.fluor.com or upon request from our Investor Relations Department at (469) 398-7222. We cannot control such risk factors and other uncertainties, and in many cases, cannot predict the risks and uncertainties that could cause actual results to differ materially from those indicated by the forward-looking statements. These risks and uncertainties should be considered when evaluating Fluor and deciding whether to invest in our securities. Except as otherwise required by law, we undertake no obligation to publicly update or revise our forward-looking statements, whether as a result of new information, future events or otherwise.
Results of Operations
We have decided to retain Stork's North American operations, which largely consists of our operations and maintenance business owned by Fluor prior to our acquisition of Stork. Beginning in the 2023 Quarter, this business line, renamed Plant & Facility Services, is included in our Urban Solutions segment for all periods presented.
In March 2023, we sold our AMECO South America business, which included operations in Chile and Peru. This transaction marks the completion of the AMECO divestiture for total proceeds of $144 million, including $17 million during the 2023 Quarter. Previous AMECO divestitures included assets in Africa, the Caribbean, Mexico and North America. Upon the sale of AMECO South America in the 2023 Quarter, we recognized a $60 million negative earnings impact, including $35 million for foreign currency translation.
In 2021, we committed to achieving net zero emissions for Scopes 1 and 2 absolute greenhouse gas emissions by the end of 2023, and we are on track to meet that objective.
21

Table of Contents

|  | 3ME March 31,
(in millions) |  | 2023 |  | 2022
Revenue |  |  |  |  |  |
Energy Solutions |  | $ | 1,612 |  |  |  | $ | 1,174 |  |
Urban Solutions |  | 1,208 |  |  |  | 1,061 |  |
Mission Solutions |  | 649 |  |  |  | 593 |  |
Other |  | 283 |  |  |  | 294 |  |
Total revenue |  | $ | 3,752 |  |  |  | $ | 3,122 |  |
Segment profit (loss) $ and margin % |  |  |  |  |  |
Energy Solutions |  | $ | 88 |  | 5.5 | % |  | $ | 54 |  | 4.6 | %
Urban Solutions |  | (20) |  | (1.7) | % |  | 17 |  | 1.6 | %
Mission Solutions |  | 7 |  | 1.1 | % |  | 58 |  | 9.8 | %
Other |  | (90) |  | NM |  | (14) |  | NM
Total segment profit (loss) $ and margin % (1) |  | $ | (15) |  | (0.4) | % |  | $ | 115 |  | 3.7 | %
G&A |  | (62) |  |  |  | (71) |  |
Impairment |  | — |  |  |  | 63 |  |
Foreign currency loss |  | (41) |  |  |  | (19) |  |
Interest income (expense), net |  | 41 |  |  |  | (9) |  |
Earnings (loss) attributable to NCI |  | (23) |  |  |  | 8 |  |
Earnings (loss) before taxes |  | (100) |  |  |  | 87 |  |
Income tax expense |  | (30) |  |  |  | (31) |  |
Net earnings (loss) |  | (130) |  |  |  | 56 |  |
Less: Net earnings (loss) attributable to NCI |  | (23) |  |  |  | 8 |  |
Net earnings (loss) attributable to Fluor |  | $ | (107) |  |  |  | $ | 48 |  |
New awards |  |  |  |  |  |
Energy Solutions |  | $ | 712 |  |  |  | $ | 682 |  |
Urban Solutions |  | 1,775 |  |  |  | 620 |  |
Mission Solutions |  | 331 |  |  |  | 386 |  |
Other |  | 416 |  |  |  | 238 |  |
Total new awards |  | $ | 3,234 |  |  |  | $ | 1,926 |  |
New awards related to projects located outside of the U.S. |  | 53% |  |  | 36% |
Backlog |  | March 31, 2023 |  |  | December 31, 2022 |
Energy Solutions |  | $ | 8,558 |  |  |  | $ | 9,134 |  |
Urban Solutions |  | 10,656 |  |  |  | 10,270 |  |
Mission Solutions |  | 5,238 |  |  |  | 5,666 |  |
Other |  | 1,171 |  |  |  | 979 |  |
Total backlog |  | $ | 25,623 |  |  |  | $ | 26,049 |  |
Backlog related to projects located outside of the U.S. |  | 49% |  |  | 49% |
Backlog related to reimbursable projects |  | 64% |  |  | 63% |

(1) Total segment profit is a non-GAAP financial measure. We believe that total segment profit provides a meaningful perspective on our results as it is the aggregation of individual segment profit measures that we use to evaluate and manage our performance.
While we experienced reductions in demand for certain services and the delay or abandonment of ongoing or anticipated projects during the COVID pandemic, our ability to win work was not materially impacted by COVID during the 2023 Quarter. Although many of our projects are in a state we consider normal, we continue to deal with the effects of COVID on our operating results as our estimates are inclusive of COVID effects and client recoveries.
22

Table of Contents
During the 2023 Quarter, consolidated revenue increased due to the ramp up of execution activities on several recently awarded Energy Solutions and Urban Solutions projects partially offset by declines in the volume of execution activity for projects which were completed or nearing completion.
Segment profit during the 2023 Quarter includes a $59 million charge for rework associated with subcontractor design errors, related schedule impacts and system integration testing timelines on the LAX Automated People Mover project and a $21 million charge for cost growth resulting from government directed change orders and the associated schedule delays on a weapons facility project as well as the $60 million negative earnings impact upon the sale of our AMECO South America business.
We did not recognize any material impairment expense during the 2023 Quarter. During the 2022 Quarter, we reversed $63 million in impairment originally recognized in 2021 when our Stork and AMECO businesses were classified as held for sale due primarily to remeasurement under held and used impairment criteria, for which CTA balances are excluded from carrying value.
The effective tax rate on earnings for the 2023 Quarter was (30.1)% compared to 35.4% for the 2022 Quarter. A reconciliation of U.S. statutory federal income tax expense to income tax expense follows:

| 3ME March 31
(In millions) | 2023 |  | 2022
U.S. statutory federal tax expense (benefit) | $ | (21) |  |  | $ | 18 |
Increase (decrease) in taxes resulting from: |  |  |
State and local income taxes, net of federal income tax effects | (3) |  |  | 1 |
Valuation allowance | 52 |  |  | 16 |
Foreign tax effects | 8 |  |  | 2 |
Noncontrolling interest | 5 |  |  | (2) |
Sale of AMECO South America | (10) |  |  | — |
Other adjustments | (1) |  |  | (4) |
Total income tax expense | $ | 30 |  |  | $ | 31 |

Backlog as of March 31, 2023 remained flat compared to December 31, 2022. Although backlog reflects business that is considered to be firm, cancellations, deferrals or scope adjustments may occur. Backlog is adjusted to reflect any known project cancellations, revisions to project scope and cost, foreign currency exchange fluctuations and project deferrals, as appropriate. Backlog differs from RUPO discussed elsewhere. RUPO includes only the amount of revenue we expect to recognize under contracts with definite terms and substantive termination provisions.
Segment Operations
Energy Solutions
Revenue in 2023 significantly increased due to the ramp up of execution activities on recently awarded mid-scale LNG projects, recently awarded chemicals projects in China, refinery projects in Mexico as well as a favorable foreign currency remeasurement effect on a project with multiple currencies. The 2023 revenue increase was partially offset by declines in the volume of execution activity for projects nearing completion.
Segment profit in 2023 increased due to the ramp up of execution activities on the refinery projects in Mexico and the mid-scale LNG projects as well as a $22 million favorable foreign currency remeasurement effect on a project with multiple currencies. The increase in segment profit was partially offset by an increase in expense on embedded foreign currency derivatives. The increase in segment profit margin in 2023 reflects these same factors.
New awards remained flat during the 2023 Quarter. The decline in backlog during the 2023 Quarter resulted from work performed outpacing new award activity.
Urban Solutions
Revenue in 2023 increased primarily due to the ramp up of execution activities on a large metals project in the U.S., a life sciences project, a recently awarded advanced technologies project and a mining project. The 2023 revenue increase was
23

Table of Contents
partially offset by declines in the volume of execution activity for a large mining project nearing completion as well as forecast revisions on a legacy infrastructure project.
Segment profit in 2023 reflects a $59 million charge for rework associated with subcontractor design errors, related schedule impacts and system integration testing timelines on the LAX Automated People Mover project. The decline in segment profit was partially offset by the favorable resolution of close out items on an advanced manufacturing project. The decline in segment profit margin in 2023 reflects these same factors.
New awards in 2023 increased due to a large advanced manufacturing project and an advanced technologies project. Backlog increased during 2023 due to the new award activity. Our staffing business does not report new awards or backlog.
Mission Solutions
Revenue in 2023 increased due to increased execution activities on three DOE contracts partially offset by the completion of a humanitarian support project and the favorable resolution of close out items on a completed Army Corps of Engineers project in the 2022 Quarter.
The decline in segment profit in 2023 was substantially driven by a $21 million charge for cost growth resulting from government directed change orders and the associated schedule delays on a weapons facility project as well as the completion of the humanitarian support project and the favorable resolution of the Army Corps of Engineers project in the 2022 Quarter. The decline in segment profit margin was driven by these same factors.
New awards remained flat during the 2023 Quarter. New awards in the 2023 Quarter included a 6-month contract extension on a DOE project. The decline in backlog during the 2023 Quarter resulted from work performed outpacing new award activity. Backlog included $3.0 billion and $3.9 billion of unfunded government contracts as of March 31, 2023 and December 31, 2022, respectively. Unfunded backlog reflects our estimate of future revenue under awarded government contracts for which funding has not yet been appropriated.
Other
Other includes the operations of NuScale, Stork and the remaining AMECO business.

| 3ME March 31,
(in millions) | 2023 |  | 2022
NuScale (1) | $ | (29) |  |  | $ | (21) |
Stork | 1 |  |  | 4 |
AMECO | (62) |  |  | 3 |
Segment profit (loss) | $ | (90) |  |  | $ | (14) |
(1) NuScale expenses included in the determination of segment profit were as follows: |  |  |
NuScale expenses | $ | (58) |  |  | $ | (45) |
Less: DOE reimbursable expenses | 8 |  |  | 23 |
NuScale expenses, net | (50) |  |  | (22) |
Less: Attributable to NCI | 21 |  |  | 1 |
NuScale profit (loss) | $ | (29) |  |  | $ | (21) |

Segment profit in 2023 includes the $60 million negative earnings impact upon the sale of our AMECO South America business, including $35 million for foreign currency translation.
24

Table of Contents
G&A

| 3ME March 31,
(in millions) | 2023 |  | 2022
G&A |  |  |
Compensation | $ | 43 |  |  | $ | 55 |
SEC investigation | 5 |  |  | 5 |
Facilities | 4 |  |  | 6 |
Exit costs | 1 |  |  | — |
Other | 9 |  |  | 5 |
G&A | $ | 62 |  |  | $ | 71 |

Stock price driven compensation declined during the 2023 Quarter due to the decline in our stock price from December 31, 2022 to March 31, 2023.
Net Interest Income (Expense)
The increase in net interest income during the 2023 Quarter was primarily due to an increase in interest rates earned on cash deposits including at our joint ventures in Canada and Mexico as well as the redemption of the 2023 Notes.
Critical Accounting Policies and Estimates
There have been no material changes in our critical accounting policies and estimates from those disclosed in our 2022 10-K.
Recent Accounting Pronouncements
Item is described more fully in the Notes to Financial Statements.
LIQUIDITY AND FINANCIAL CONDITION
Our liquidity arises from available cash and cash equivalents and marketable securities, cash generated from
operations, capacity under our credit facilities and, when necessary, access to capital markets. We have committed and uncommitted lines of credit available for revolving loans and letters of credit. We believe that for at least the next 12 months, anticipated cash generated from operations, along with our unused credit capacity and cash position, is sufficient to support operating requirements and debt maturities. We regularly review our sources and uses of liquidity and may pursue opportunities to address our liquidity needs.
Our credit facility contains provisions that will require us to provide collateral to secure the facility should we be downgraded to BB by S&P and Ba2 by Moody's, which is a one notch downgrade from both of our current ratings. If we are required to provide collateral, it would consist broadly of liens on our U.S. assets.
In January 2023, we redeemed the remaining €129 million of outstanding 2023 Notes for $140 million using cash on hand. We expect to address the maturity of the 2024 Notes through available liquidity, cash generated by our operations or via a new securities issue. However, we aspire to partially retire some portion of the 2024 Notes during 2023 using organic sources.
As of March 31, 2023, letters of credit t otaling $420 million were outstanding under our $1.8 billion credit facility, which was amended in February 2023 to extend the maturity to February 2026. This credit facility contains customary financial covenants, including a debt-to-capitalization ratio that cannot exceed 0.60 to 1.00, a limitation on the aggregate amount of debt of the greater of $750 million or €750 million for our subsidiaries, and a minimum liquidity threshold of $1.1 billion, all as defined in the amended credit facility. Borrowings under the facility, which may be denominated in USD, EUR, GBP or CAD, bear interest at a base rate, plus an applicable borrowing margin. As of March 31, 2023 and through the issuance of this 10-Q, we had not made any borrowings under our credit line and maintained a borrowing capacity of $828 million.
25

Table of Contents
Cash and cash equivalents combined with marketable securities were $2.3 billion as of March 31, 2023 and $2.6 billion as of December 31, 2022. Cash balances as of March 31, 2023 and December 31, 2022 include cash and cash equivalents and marketable securities held by NuScale of $268 million and $338 million, respectively. Cash and cash equivalents are held in numerous accounts throughout the world to fund our global project execution activities. Non-U.S. cash and cash equivalents amounted to $1.1 billion as of both March 31, 2023 and December 31, 2022, respectively. Non-U.S. cash and cash equivalents exclude deposits of U.S. legal entities that are invested in offshore, overnight accounts or short-term time deposits, to which there is unrestricted access.
In evaluating our liquidity needs, we consider cash and cash equivalents held by our consolidated variable interest entities (joint ventures and partnerships). These amounts (which totaled $642 million and $706 million as of March 31, 2023 and December 31, 2022, respectively) were not necessarily readily available for general purposes. We do not include our share of cash held by our proportionately consolidated joint ventures and partnerships in our consolidated cash balances even though these amounts may be significant. We also consider the extent to which client advances (which totaled $111 million and $102 million as of March 31, 2023 and December 31, 2022, respectively) are likely to be sustained or consumed over the near term for project execution activities and the cash flow requirements of our various foreign operations. In some cases, it may not be financially efficient to move cash and cash equivalents between countries due to statutory dividend limitations and/or adverse tax consequences. We did not consider any cash to be permanently reinvested outside the U.S. as of March 31, 2023 and December 31, 2022, other than unremitted earnings required to meet our working capital and long-term investment needs in non-U.S. foreign jurisdictions where we operate.

|  | 3ME March 31,
(in millions) |  | 2023 |  | 2022
OPERATING CASH FLOW |  | $ | (161) |  |  | $ | (188) |
INVESTING CASH FLOW |  |  |  |
Proceeds from sales and maturities (purchases) of marketable securities |  | 11 |  |  | (76) |
Capital expenditures |  | (20) |  |  | (10) |
Proceeds from sales of assets incl. AMECO-South America |  | 22 |  |  | 3 |
Investments in partnerships and joint ventures |  | (2) |  |  | (24) |
Other |  | 2 |  |  | 2 |
Investing cash flow |  | 13 |  |  | (105) |
FINANCING CASH FLOW |  |  |  |
Purchases and retirement of debt |  | (137) |  |  | — |
Dividends paid on CPS |  | (10) |  |  | (10) |
Other borrowings (debt repayments) |  | 2 |  |  | 7 |
Distributions paid to NCI |  | — |  |  | (7) |
Capital contributions by NCI |  | 1 |  |  | — |
Other |  | (17) |  |  | (6) |
Financing cash flow |  | (161) |  |  | (16) |
Effect of exchange rate changes on cash |  | 7 |  |  | 13 |
Increase (decrease) in cash and cash equivalents |  | (302) |  |  | (296) |
Cash and cash equivalents at beginning of period |  | 2,439 |  |  | 2,209 |
Cash and cash equivalents at end of period |  | $ | 2,137 |  |  | $ | 1,913 |

Operating Activities
Cash flows from operating activities result primarily from our EPC activities and are affected by our earnings level and changes in working capital associated with such activities. Working capital levels vary from period to period and are primarily affected by our volume of work and billing schedules on our projects. These levels are also impacted by the stage of completion and commercial terms of engineering and construction projects, as well as our execution of our projects compared to their budget. Working capital requirements also vary by project and the payments terms agreed to with our clients, vendors and subcontractors. Most contracts require payments as the projects progress. Additionally, certain projects receive advance payments from clients. A typical trend for our lump-sum projects is to have higher cash balances during the initial phases of execution due to deposits paid to us which then diminish toward the end of the construction phase. As a
26

Table of Contents
result, our cash position is reduced as customer advances are utilized, unless they are replaced by advances on other projects. We maintain cash reserves and borrowing facilities to provide additional working capital in the event that a project’s net operating cash outflows exceed its available cash balances. As of March 31, 2023, our backlog included $1.7 billion for loss projects which may have a negative impact on our operating cash flow in future periods.
Our operating cash flow is typically lower in the first quarter of each year due to the timing of payout of employee incentive awards from the prior year. Our operating cash flow for the 2023 and 2022 Quarters was also negatively impacted by increases in working capital on several large projects. During the 2023 Quarter, we funded an estimated $15 million on loss projects.
Investing Activities
We hold cash in bank deposits and marketable securities which a re governed by our investment policy. This policy focuses on, in order of priority, the preservation of capital, maintenance of liquidity and maximization of yield. These investments may include money market funds, bank deposits placed with highly-rated financial institutions, repurchase agreements that are fully collateralized by U.S. Government-related securities, high-grade commercial paper and high quality short-term and medium-term fixed income securities.
Capital expenditures are primarily related to construction equipment on certain infrastructure projects as well as expenditures for facilities and investments in IT.
Proceeds from sales of assets during the 2023 Quarter included $17 million for the sale of our AMECO South America business, which included operations in Chile and Peru.
Investments in unconsolidated partnerships and joint ventures in the 2022 Quarter included capital contributions to a recently formed Mission Solutions joint venture.
Financing Activities
In January 2023, we redeemed the remaining €129 million of outstanding 2023 Notes for $140 million with no earnings impact.
Cumulative cash dividends on the CPS are payable at an annual rate of 6.5% quarterly in arrears on February 15, May 15, August 15 and November 15, upon declaration of the dividend by our Board of Directors. Dividends accumulate from the most recent date on which dividends have been paid. First quarter CPS dividends of $10 million were paid in February 2023. In April 2023, our Board of Directors approved the payment of second quarter CPS dividends of $10 million, payable in May 2023.
Each share of CPS is convertible at the holder's option at any time into 44.9585 shares of our common stock per share of CPS. The conversion rate is subject to certain customary adjustments, but no payment or adjustment for accumulated but unpaid dividends will be made upon conversion, subject to certain limited exceptions. The CPS may not be redeemed by us; however, we are able, since May 20, 2022, to elect to cause all outstanding shares of CPS to be converted into shares of our common stock at the conversion rate, subject to certain conditions (and, if such conversion occurs prior to May 20, 2024, the payment of a cash make-whole premium). The most significant condition to our ability to invoke a conversion prior to May 2024 is the requirement that our common stock trade above $28.92 for 20 consecutive trading days, which occurred in the fourth quarter of 2022 and persisted through March 31, 2023. We estimate that the cash make-whole payment would have been $61 million at March 31, 2023 (assuming we minimally exceeded the minimum trading price to invoke the conversion) or $60 million (using the actual average 5-day trading price leading up to March 31, 2023). If a make-whole fundamental change, as defined in the certificate of designations for the CPS, occurs, we will in certain circumstances be required to increase the conversion rate for a holder who elects to convert shares of CPS in connection with such make-whole fundamental change.
Distributions paid to holders of NCI represent cash outflows to partners of consolidated partnerships or joint ventures created primarily for the execution of single contracts or projects. Distributions in the 2022 Quarter primarily related to a petrochemical joint venture project in Canada. Capital contributions by NCI during the 2023 Quarter related to investments by NuScale's NCI holders.
We have a common stock repurchase program, authorized by our Board of Directors, to purchase shares in the open market or privately negotiated transactions at our discretion. As of March 31, 2023, over 10 million shares could still be purchased under the existing stock repurchase program, although we do not have any immediate intent to begin such repurchases.
27

Table of Contents
Letters of Credit
As of March 31, 2023, letters of credit totaling $420 million were outstanding under committed lines of credit and letters of credit totaling $957 million were outstanding under uncommitted lines of credit. Letters of credit are ordinarily provided to indemnify our clients if we fail to perform our obligations under our contracts. Surety bonds may be used as an alternative to letters of credit.
Guarantees
The maximum potential amount of future payments that we could be required to make under outstanding performance guarantees, which represents the remaining cost of work to be performed, was estimated to be $15 billion as of March 31, 2023.
Financial guarantees, made in the ordinary course of business in certain limited circumstances, are entered into with financial institutions and other credit grantors and generally obligate us to make payment in the event of a default by the borrower. These arrangements generally require the borrower to pledge collateral to support the fulfillment of the borrower’s obligation.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
There have been no material changes to market risk during the 2023 Quarter. Accordingly, the disclosures provided in the 2022 10-K remain relevant.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Based on their evaluation as of the end of the period covered by this report, our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) or 15d-15(e) of the Exchange Act) are effective as required by paragraph (b) of Rule 13a-15 or Rule 15d-15 of the Exchange Act.
Changes in Internal Control over Financial Reporting
There were no changes to our ICFR that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our ICFR.
28

Table of Contents
FLUOR CORPORATION
CHANGES IN CONSOLIDATED BACKLOG
UNAUDITED

|  | 3ME March 31,
(in millions) |  | 2023 |  | 2022
Backlog, January 1 |  | $ | 26,049 |  |  | $ | 20,800 |
New awards |  | 3,234 |  |  | 1,926 |
Adjustments and cancellations, net |  | 52 |  |  | (398) |
Work performed |  | (3,712) |  |  | (3,074) |
Backlog, March 31 |  | $ | 25,623 |  |  | $ | 19,254 |

29

Table of Contents
PART II: OTHER INFORMATION
Item 1. Legal Proceedings
As part of our normal business activities, we are party to a number of legal proceedings and other matters in various stages of development. Management periodically assesses our liabilities and contingencies in connection with these matters based upon the latest information available. We disclose material pending legal proceedings pursuant to SEC rules and other pending matters as we may determine to be appropriate.
Additional information on matters in dispute may be found in Part I, Item 1 of this Q1 2023 10-Q.
Item 1A. Risk Factors
There have been no material changes from our risk factors as disclosed in the 2022 10-K.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
(c) The following table provides information for the quarter ended March 31, 2023 about purchases by the company of equity securities that have been registered pursuant to Section 12 of the Exchange Act.
Issuer Purchases of Equity Securities

Period |  | Total Number of Shares Purchased |  | Average Price Paid per Share |  | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs |  | Maximum Number of Shares that May Yet Be Purchased Under the Plans or Program (1)
January 1 — January 31, 2023 |  | — |  |  | $ | — |  |  | — |  |  | 10,513,093 |
February 1 — February 28, 2023 |  | — |  |  | — |  |  | — |  |  | 10,513,093 |
March 1 — March 31, 2023 |  | — |  |  | — |  |  | — |  |  | 10,513,093 |
Total |  | — |  |  | $ | — |  |  | — |  |  |

_________________________________________________________
(1) The share repurchase program, as amended, totals 34,000,000 shares. We may repurchase shares from time to time in open market or privately negotiated transactions, including through pre-arranged trading programs, at our discretion, subject to market conditions and other factors and at such time and in amounts that we deem appropriate.
Item 4. Mine Safety Disclosures
None.
30

Table of Contents
Item 6. Exhibits
EXHIBIT INDEX

Exhibit |  | Description
3.1 |  | Amended and Restated Certificate of Incorporation of the registrant (incorporated by reference to Exhibit 3.1 to the registrant's Current Report on Form 8-K (Commission file number 1-16129) filed on May 8, 2012).
3.2 |  | Certificate of Designations, Preferences and Rights of Series A 6.50% Cumulative Preferred Perpetual Convertible Preferred Stock of the registrant (incorporated by reference to Exhibit 3.2 to the registrant's Current Report on Form 8-K (Commission file number 1-16129) filed on May 18, 2021.
3.3 |  | Amended and Restated Bylaws of the registrant (incorporated by reference to Exhibit 3.1 to the registrant's Current Report on Form 8-K (Commission file number 1-16129) filed on November 4, 2022).
10.1 |  | Form of Option Agreement (2023 grant) under the Fluor Corporation 2020 Performance Incentive Plan.*
10.2 |  | Form of Restricted Stock Unit Agreement (2023 grant) under the Fluor Corporation 2020 Performance Incentive Plan.*
10.3 |  | Form of Performance Award (2023 grant) under the Fluor Corporation 2020 Performance Incentive Plan.*
31.1 |  | Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
31.2 |  | Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
32.1 |  | Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*
32.2 |  | Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*
101.INS |  | Inline XBRL Instance Document.*
101.SCH |  | Inline XBRL Taxonomy Extension Schema Document.*
101.CAL |  | Inline XBRL Taxonomy Extension Calculation Linkbase Document.*
101.LAB |  | Inline XBRL Taxonomy Extension Label Linkbase Document.*
101.PRE |  | Inline XBRL Taxonomy Extension Presentation Linkbase Document.*
101.DEF |  | Inline XBRL Taxonomy Extension Definition Linkbase Document.*
104 |  | The cover page from our Q1 2023 10-Q for the three months ended March 31, 2023, formatted in Inline XBRL (included in the Exhibit 101 attachments).*

_______________________________________________________________________
* New exhibit filed with this report.
31

Table of Contents
SIGNATURES
Pursuant to the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

|  |  | FLUOR CORPORATION
Date: | May 5, 2023 | By: | /s/ Joseph L. Brennan
|  |  | Joseph L. Brennan
|  |  | Chief Financial Officer
Date: | May 5, 2023 | By: | /s/ John C. Regan
|  |  | John C. Regan
|  |  | Chief Accounting Officer

32